PharmaShots | Incisive News in 3 Shots

Subscribe Now

Daratumumab

Janssen Reports sBLA Submission to the US FDA for Darzalex Faspro (daratumumab and hyaluronidase-fihj) to Treat Patients with Light Chain (AL) Amyloidosis

Janssen Reports sBLA Submission to the US FDA for Darzalex Faspro (daratumumab and hyaluronidase-fihj) to Treat Patients with Ligh...

September 11, 2020

The US FDA Approves Kyprolis (carfilzomib) + Darzalex (daratumumab) + Dexamethasone in Two Dosing Regimens for R/R Multiple Myeloma

The US FDA Approves Kyprolis (carfilzomib) + Darzalex (daratumumab) + Dexamethasone in Two Dosing Regimens for R/R Multiple Myelom...

August 21, 2020

Janssen's Darzalex (daratumumab- SC) Receives Health Canada Approval for the Treatment of Patients with Multiple Myeloma

Janssen's Darzalex (daratumumab- SC) Receives Health Canada Approval for the Treatment of Patients with Multiple Myeloma

August 4, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us